MARATTO

article · Aquaculture Reports

Dietary treatment of Nile tilapia (Oreochromis niloticus) with aquatic fern (Azolla caroliniana) improves growth performance, immunological response, and disease resistance against Streptococcus agalactiae cultured in bio-floc system

202234 citationsOpen accessKafr el-Sheikh University

In plain language

Supplementing the diet of Nile tilapia reared in biofloc systems with the aquatic fern Azolla caroliniana improves growth, feed efficiency, and immune defences. Across an eight-week trial evaluating inclusion levels between 0 and 200 grams per kilogram of feed, tilapia receiving 100 grams per kilogram achieved the best overall growth and feed utilisation. Diets supplemented with the aquatic fern also enhanced skin mucus and serum immune indicators compared to control diets. When challenged with the bacterial pathogen Streptococcus agalactiae, fish fed the aquatic fern exhibited substantially improved survival rates, peaking at over 83 percent survival in the group fed 100 grams per kilogram, compared with under 27 percent in the control group. Overall, an inclusion rate of 100 grams per kilogram shows clear potential as a functional feed additive to bolster productivity and disease resistance.

Key takeaways

  • Diets supplemented with the aquatic fern Azolla caroliniana significantly improved the growth rate and feed efficiency of Nile tilapia.
  • A feed inclusion rate of 100 grams of aquatic fern per kilogram provided the highest growth performance and immune benefits.
  • Tilapia fed 100 grams per kilogram of aquatic fern achieved an 83.33 percent survival rate when challenged with Streptococcus agalactiae, compared to 26.67 percent in the control group.
  • Aquatic fern supplementation enhanced both skin mucus and serum immunological responses in biofloc-reared fish.

Why it matters

Bacterial diseases such as Streptococcus agalactiae cause heavy losses in commercial aquaculture. Using plant-based supplements like aquatic ferns provides fish farmers with a practical, natural method to boost fish immunity, reduce disease mortality, and improve feed efficiency without relying on synthetic chemicals or antibiotics.

Commercialisation angle

This research provides applied and tested evidence for fish feed manufacturers and tilapia producers operating biofloc aquaculture systems. The aquatic fern could be formulated into commercial feed additives to stimulate growth and protect stock from streptococcal infections. Further commercialisation will require scaling feed production, verifying shelf life, and confirming efficacy under commercial farm conditions beyond controlled tank trials.

AI-generated from the published abstract. Always read the original work before citing.

Abstract

The present study was performed to examine the effects of aquatic fern (Azolla caroliniana) (AQF) on growth performance, skin mucus and serum immunities, and disease resistance of Nile tilapia reared in a biofloc system. Three hundred Nile tilapia fingerlings (average 10.48 ± 0.56 g fish-1) were distributed into 15 glass tanks (150 liters tank−1) at a concentration of 20 fish tank−1. A completely randomized design was used in triplicates, where the control group was fed 0 g kg−1 AQF (AQF1), while AQF2, AQF3, AQF4, and AQF5 were fed 25, 50, 100, and 200 g kg−1 AQF, respectively. Growth and immunological specimens were collected every 4 weeks, while disease resistance was conducted after 8 weeks post-feeding. The results showed that dietary administration of AQF significantly promoted the growth rate and feed efficiency of Nile tilapia, with the maximum level noticed in fish fed 100 g kg−1 AQF. However, no significant differences were observed between the AQF1 and AQF5 diets. Similarly, incorporation of AQF resulted in significantly higher skin mucus and serum immunities than the control, except for AQF5. The highest values were observed in fish fed the AQF5 diet. The challenge test showed that in contrast to the control (26.67%), the AQF administrated diets led to significantly higher survivability by 60% (AQF2), 66.67% (AQF3), 83.33% (AQF4), and 53.33 for AQF5. The relative percent survival (RPS) was 45.45%, 54.55%, 77.27%, and 36.36% in AQF2, AQF3, AQF4, and AQF5, respectively. The highest RPS against S. agalactiae was noted in the AQF4 diet. In conclusion, dietary supplementation of 100 g kg−1 AQF can be potentially used as a growth promoter and immunostimulant in Nile tilapia aquaculture.

Research topics

  • Aquaculture Nutrition and Growth
  • Aquatic life and conservation
  • Fish Biology and Ecology Studies

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.aqrep.2022.101114

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.